Richard Heuser, MD
Interventional Cardiology · Phoenix, AZNPI 1962493338
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $54,231 of the $68,434 with a category attached, or 79.2%. Boston Scientific accounts for 79.4% of it on its own, with 41 other manufacturers making up the rest. Reporting peaked in 2019 at $59,176 and has fallen 100.0% since, to $18 in 2025. Among interventional cardiology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $313.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$54K
- Siemens Medical Solutions USA, Inc.$4K
- Penumbra, Inc.$2K
- Amgen$2K
- Medtronic$2K
- Microvention, Inc.$1K
- plus $4K from 36 others
Across 17 payments — averaging $2557.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cardiovascular Systems Inc.$40K
- Bard Peripheral Vascular, Inc.$4K
What the payments were for
- Consulting fees$5,1007%
- Speaking & faculty fees$1,2502%
- Travel & lodging$1,5302%
- Food & beverage$6,3239%
- Ownership interest$54,23179%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$54,231
- Indigo$2,201
- ROADSAVER$1,250
- Repatha$434
- Confirm Rx$312
- Coronary Orbital Atherectomy System$152
- CorPath Imaging System$146
- Auryon Laser System 100-120 Vac$138
- Livalo$132
- Sublime 014 Rx PTA Balloon Dilatation Catheter$115
- Sublime Radial Access 018 RX PTA Dilatation Catheter$115
- Sublime Radial Access Guide Sheath$115
- Pounce Thrombectomy$115
- Pounce Venous Thrombectomy System$115
- HawkOne$105
How this compares
$68,434 in reported general payments places this provider in the 90th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 26 | $37,827 |
| FarxigaDapagliflozin Propanediol | 11 | $11,933 |
| NexletolBempedoic Acid | 14 | $6,417 |
| Atorvastatin Calcium | 118 | $1,067 |
| ClopidogrelClopidogrel Bisulfate | 95 | $1,064 |
| Ezetimibe | 39 | $910 |
| Metoprolol Succinate | 44 | $629 |
| Chlorthalidone | 37 | $577 |
| Amlodipine Besylate | 59 | $402 |
| Carvedilol | 34 | $383 |
| Lisinopril | 50 | $333 |
| Losartan Potassium | 25 | $327 |
| Metoprolol Tartrate | 28 | $278 |
| Rosuvastatin Calcium | 29 | $266 |
| Simvastatin | 13 | $184 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $24 | $37,82726 claims |
| AstraZenecaFarxiga | $61 | $11,93311 claims |
| Esperion Therapeutics, Inc.Nexletol | $29 | $6,41714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 223 interventional cardiology providers in Arizona.
Other interventional cardiology in Phoenix
- Paul SorajjaPhoenix$1.1M
- Timothy ByrnePhoenix$614K
- Haidar YassinPhoenix$434K
- Akil LoliPhoenix$160K
- Nishant GuptaPhoenix$145K
- Nezar FallujiPhoenix$50K
- Ahmad JabriPhoenix$39K
- Edward EvansPhoenix$36K
- Basil Al KhatibPhoenix$33K
- Sourabh AggarwalPhoenix$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.